ADO 30.0% 2.6¢ anteotech ltd

Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-25

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,831 Posts.
    lightbulb Created with Sketch. 640
    Not hard to guess.

    So not only was the strategic focus misguided, they botched the European trial in such a way that it was mismanaged in a particular region permanently destroying the credibility of the product. Can't unring that bell.

    So depressing.


    Last edited by JustIntonation: 02/11/22
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.6¢
Change
0.006(30.0%)
Mkt cap ! $64.73M
Open High Low Value Volume
2.0¢ 2.9¢ 2.0¢ $356.3K 14.20M

Buyers (Bids)

No. Vol. Price($)
4 295200 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 4229 1
View Market Depth
Last trade - 16.10pm 15/10/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.